Related Experiment Video

Updated: Aug 20, 2025

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.3K

Coronavirus Disease-2019 and Implications on the Liver

Patrick T Campbell1, Oren K Fix1

  • 1Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Burnett-Womack Building, Campus Box 7584, Chapel Hill, NC 27599-7584, USA.

Clinics in Liver Disease
|November 18, 2022
PubMed

Insights

Patients with chronic liver disease (CLD) and liver transplant (LT) recipients face higher risks from COVID-19. Vaccination offers protection, but its efficacy may be reduced in immunosuppressed individuals like LT recipients.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Immunology

Background:

  • The COVID-19 pandemic significantly impacts patients with chronic liver disease (CLD) and liver transplant (LT) recipients.
  • Advanced CLD increases the risk of severe outcomes from SARS-CoV-2 infection.
  • Pandemic conditions have altered the management and care protocols for CLD and LT patients.

Purpose of the Study:

  • To summarize the impact of the COVID-19 pandemic on CLD and LT patient populations.
  • To review the role of COVID-19 vaccination in protecting these vulnerable groups.
  • To assess the safety and efficacy of COVID-19 vaccines in CLD and LT recipients.

Main Methods:

  • Literature review and synthesis of current evidence regarding COVID-19 in CLD and LT patients.
  • Analysis of clinical outcomes, management strategies, and vaccination data.
  • Evaluation of vaccine safety and efficacy in immunocompromised populations.

Main Results:

  • Patients with advanced CLD have a substantially higher risk of adverse outcomes following SARS-CoV-2 infection.
  • COVID-19 vaccination is protective and safe for CLD and LT recipients.
  • Reduced vaccine efficacy is noted in LT recipients and other immunosuppressed individuals.

Conclusions:

  • COVID-19 vaccination is crucial for mitigating risks in CLD and LT patients.
  • Ongoing monitoring and research are needed to optimize vaccine strategies for immunosuppressed populations.
  • Management of CLD and LT patients requires adaptation to the ongoing pandemic landscape.

Keywords:
CirrhosisImmunosuppressionSARS-CoV-2TransplantVaccination

More Related Videos

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-208:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

2.9K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.3K

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
877
Liver Physiology01:30

Liver Physiology

The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
892
Gross Anatomy of the Liver01:17

Gross Anatomy of the Liver

The liver, the largest gland within the human body, is a firm and reddish-brown organ. This wedge-shaped structure weighs approximately 1.5 kg and occupies a significant portion of the right hypochondriac and epigastric regions. It extends more to the right of the body's midline than to the left.
Located under the diaphragm, the liver is almost entirely ensconced within the rib cage, providing it with substantial protection. Except for the superior most bare area, the liver's surface is...
763
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
120
Hepatic Portal System01:21

Hepatic Portal System

The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
1.7K
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
185